CTI BIOPHARMA CORP Quarterly Net Cash Provided by (Used in) Operating Activities in USD from Q1 2011 to Q1 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Cti Biopharma Corp quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q1 2011 to Q1 2023.
- Cti Biopharma Corp Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2023 was -$31.1M, a 3.74% decline year-over-year.
- Cti Biopharma Corp annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$81.2M, a 4.35% increase from 2021.
- Cti Biopharma Corp annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$84.9M, a 101% decline from 2020.
- Cti Biopharma Corp annual Net Cash Provided by (Used in) Operating Activities for 2020 was -$42.2M, a 51.7% decline from 2019.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)